14-day Premium Trial Subscription Try For FreeTry Free

iShares Nasdaq Biotechnology Index Fund ETF Price (Quote)

$133.28
+0.260 (+0.195%)
At Close: May 07, 2024

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 IBB stock ended at $133.28. This is 0.195% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 0.81% from a day low at $132.47 to a day high of $133.54.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical iShares Nasdaq Biotechnology Index Fund prices

Date Open High Low Close Volume
Jan 19, 2024 $134.55 $135.48 $133.45 $135.18 1 332 149
Jan 18, 2024 $134.81 $134.86 $133.43 $134.55 1 597 318
Jan 17, 2024 $135.05 $135.22 $133.89 $135.02 1 146 571
Jan 16, 2024 $136.18 $136.21 $134.85 $135.93 2 176 159
Jan 12, 2024 $137.42 $138.93 $136.85 $137.13 1 282 400
Jan 11, 2024 $137.52 $137.52 $135.45 $136.88 1 627 775
Jan 10, 2024 $138.95 $138.95 $136.82 $137.96 1 864 358
Jan 09, 2024 $138.30 $139.49 $137.64 $138.94 2 053 186
Jan 08, 2024 $135.10 $139.41 $134.53 $139.39 1 966 875
Jan 05, 2024 $135.94 $136.83 $134.24 $136.12 2 250 673
Jan 04, 2024 $136.35 $137.14 $135.81 $136.52 1 634 740
Jan 03, 2024 $137.76 $137.86 $135.40 $135.92 2 099 068
Jan 02, 2024 $134.93 $139.05 $134.65 $138.07 2 306 933
Dec 29, 2023 $137.06 $137.06 $135.60 $135.85 1 041 058
Dec 28, 2023 $136.67 $137.84 $136.51 $137.03 1 496 970
Dec 27, 2023 $135.87 $136.88 $135.30 $136.86 1 840 185
Dec 26, 2023 $134.40 $135.33 $133.71 $135.03 1 290 751
Dec 22, 2023 $131.74 $134.26 $131.74 $133.77 1 663 379
Dec 21, 2023 $129.81 $131.08 $129.81 $130.91 1 268 278
Dec 20, 2023 $131.79 $131.81 $128.85 $128.88 1 682 120
Dec 19, 2023 $131.42 $132.96 $131.27 $132.92 1 249 948
Dec 18, 2023 $132.11 $132.11 $130.36 $130.83 1 180 568
Dec 15, 2023 $133.00 $133.86 $131.18 $131.78 2 518 166
Dec 14, 2023 $132.36 $133.60 $131.95 $132.75 2 886 777
Dec 13, 2023 $126.81 $131.41 $126.57 $131.40 3 361 153
Click to get the best stock tips daily for free!

About iShares Nasdaq Biotechnology Index Fund

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representin... IBB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT